염기 편집 시장 규모, 점유율, 동향 분석 보고서 : 제품 및 서비스별, 용도별, 최종 용도별, 지역별, 부문별 예측(2025-2033년)

Base Editing Market Summary

The global base editing market size was estimated at USD 228.2 million in 2024 and is projected to reach USD 681.2 million, growing at a CAGR of 13.46% from 2025 to 2033. Rising prevalence of chronic & rare diseases, increased application of genomic research in therapeutics, and increased government funding & growing focus on genomic studies are the factors driving the base editing industry.

Advancement in Base Editing Technology

Base editing (BE), a CRISPR-Cas9 genome editing technology, offers potential therapeutic strategies against diseases. Base editing has shown significant potential in correcting genetic mutations associated with immunodeficiency disorders and chronic diseases such as cardiovascular disorders, metabolic conditions, and certain types of cancer. Moreover, base editing sensor libraries enable high-throughput screening and functional analysis of cancer-associated single nucleotide variants. The rising number of cancer cases worldwide increases the demand for novel therapeutics. For instance, in 2022, cancer was one of the leading causes of death globally, with 20 million new cases and 9.7 million deaths, according to the National Cancer Institute. By 2040, it is projected that cancer cases will reach 29.9 million, with 15.3 million cancer-related deaths.

Recent advancements in base editing technology have shown significant progress in crop genetic improvement. For instance, according to a study published in Genome Biology in February 2024, scientists have developed highly efficient base editors for cotton plants. The GhABE8e base editor exhibited 99.9% editing efficiency compared to GhABE7.10, which had 64.9% efficiency, with no off-target editing detected. Such studies provide an important technical platform and genetic information for studying and creating ideal plant architecture.

Global Base Editing Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global base editing market report based on products & services, application, type, end use, and region.

• Products & Services Outlook (Revenue, USD Million, 2021 - 2033)
• Product
  • Platform
  • Kits & Reagents
  • Plasmids
  • Base Editing Libraries
• Services
  • gRNA Design
  • Cell Line Engineering
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Drug Discovery & Development
• Agriculture
• Veterinary
• Type Outlook (Revenue, USD Million, 2021 - 2033)
• DNA Base Editing
• RNA Base Editing
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Academic & Research Institutes
• Contract Research Organizations
• Pharmaceutical & Biotechnology Companies
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
  • 1.2.1. Products & Services Segment
  • 1.2.2. Application Segment
  • 1.2.3. Type Segment
  • 1.2.4. End Use Segment
• 1.3. Information analysis
  • 1.3.1. Market formulation & data visualization
• 1.4. Data validation & publishing
• 1.5. Information Procurement
  • 1.5.1. Primary Research
• 1.6. Information or Data Analysis
• 1.7. Market Formulation & Validation
• 1.8. Market Model
• 1.9. Total Market: CAGR Calculation
• 1.10. Objectives
  • 1.10.1. Objective 1
  • 1.10.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Insights Landscape

Chapter 3. Base Editing Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rising prevalence of chronic and rare diseases
    • 3.2.1.2. Increased application of genomic research in therapeutics
    • 3.2.1.3. Increasing government funding & growing focus on genomic studies
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Ethical and safety concerns related to base editing technologies
• 3.3. Base Editing Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis

Chapter 4. Base Editing Market: Products & Services Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Base Editing Market Products & Services Movement Analysis
• 4.3. Global Base Editing Market Size & Trend Analysis, by Products & Services, 2021 to 2033 (USD Million)
• 4.4. Products
  • 4.4.1. Products market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.4.2. Platform
    • 4.4.2.1. Platform market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.4.3. Kits & Reagents
    • 4.4.3.1. Kits & reagents market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.4.4. Plasmids
    • 4.4.4.1. Plasmids market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.4.5. Base Editing Libraries
    • 4.4.5.1. Base editing libraries market estimates and forecasts 2021 to 2033 (USD Million)
• 4.5. Services
  • 4.5.1. Services market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.5.2. gRNA Design
    • 4.5.2.1. gRNA design market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.5.3. Cell Line Engineering
    • 4.5.3.1. Cell line engineering market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Base Editing Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Base Editing Market Application Movement Analysis
• 5.3. Global Base Editing Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 5.4. Drug Discovery & Development
  • 5.4.1. Drug discovery & development market estimates and forecasts 2021 to 2033 (USD Million)
• 5.5. Agriculture
  • 5.5.1. Agriculture market estimates and forecasts 2021 to 2033 (USD Million)
• 5.6. Veterinary
  • 5.6.1. Veterinary market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Base Editing Market: Type Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Base Editing Market Type Movement Analysis
• 6.3. Global Base Editing Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
• 6.4. DNA Base Editing
  • 6.4.1. DNA base editing market estimates and forecasts 2021 to 2033 (USD Million)
• 6.5. RNA Base Editing
  • 6.5.1. RNA base editing market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Base Editing Market: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global Base Editing Market End Use Movement Analysis
• 7.3. Global Base Editing Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 7.4. Academic & Research Institutes
  • 7.4.1. Academic & Research Institutes market estimates and forecasts 2021 to 2033 (USD Million)
• 7.5. Contract Research Organizations
  • 7.5.1. Contract research organizations market estimates and forecasts 2021 to 2033 (USD Million)
• 7.6. Pharmaceutical & Biotechnology Companies
  • 7.6.1. Pharmaceutical & biotechnology companies market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Base Editing Market: Regional Estimates & Trend Analysis

• 8.1. Regional Market Dashboard
• 8.2. Regional Market Share Analysis, 2024 & 2033
• 8.3. North America
  • 8.3.1. U.S.
    • 8.3.1.1. Key country dynamics
    • 8.3.1.2. Competitive scenario
    • 8.3.1.3. Regulatory framework
    • 8.3.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.3.2. Canada
    • 8.3.2.1. Key country dynamics
    • 8.3.2.2. Competitive scenario
    • 8.3.2.3. Regulatory framework
    • 8.3.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.3.3. Mexico
    • 8.3.3.1. Key country dynamics
    • 8.3.3.2. Competitive scenario
    • 8.3.3.3. Regulatory framework
    • 8.3.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
• 8.4. Europe
  • 8.4.1. UK
    • 8.4.1.1. Key country dynamics
    • 8.4.1.2. Competitive scenario
    • 8.4.1.3. Regulatory framework
    • 8.4.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.4.2. Germany
    • 8.4.2.1. Key country dynamics
    • 8.4.2.2. Competitive scenario
    • 8.4.2.3. Regulatory framework
    • 8.4.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.4.3. France
    • 8.4.3.1. Key country dynamics
    • 8.4.3.2. Competitive scenario
    • 8.4.3.3. Regulatory framework
    • 8.4.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.4.4. Italy
    • 8.4.4.1. Key country dynamics
    • 8.4.4.2. Competitive scenario
    • 8.4.4.3. Regulatory framework
    • 8.4.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.4.5. Spain
    • 8.4.5.1. Key country dynamics
    • 8.4.5.2. Competitive scenario
    • 8.4.5.3. Regulatory framework
    • 8.4.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.4.6. Denmark
    • 8.4.6.1. Key country dynamics
    • 8.4.6.2. Competitive scenario
    • 8.4.6.3. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.4.7. Sweden
    • 8.4.7.1. Key country dynamics
    • 8.4.7.2. Competitive scenario
    • 8.4.7.3. Regulatory framework
    • 8.4.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.4.8. Norway
    • 8.4.8.1. Key country dynamics
    • 8.4.8.2. Competitive scenario
    • 8.4.8.3. Regulatory framework
    • 8.4.8.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Japan
    • 8.5.1.1. Key country dynamics
    • 8.5.1.2. Competitive scenario
    • 8.5.1.3. Regulatory framework
    • 8.5.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.5.2. China
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Competitive scenario
    • 8.5.2.3. Regulatory framework
    • 8.5.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.5.3. India
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Competitive scenario
    • 8.5.3.3. Regulatory framework
    • 8.5.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.5.4. Australia
    • 8.5.4.1. Key country dynamics
    • 8.5.4.2. Competitive scenario
    • 8.5.4.3. Regulatory framework
    • 8.5.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.5.5. South Korea
    • 8.5.5.1. Key country dynamics
    • 8.5.5.2. Competitive scenario
    • 8.5.5.3. Regulatory framework
    • 8.5.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.5.6. Thailand
    • 8.5.6.1. Key country dynamics
    • 8.5.6.2. Competitive scenario
    • 8.5.6.3. Regulatory framework
    • 8.5.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
• 8.6. Latin America
  • 8.6.1. Brazil
    • 8.6.1.1. Key country dynamics
    • 8.6.1.2. Competitive scenario
    • 8.6.1.3. Regulatory framework
    • 8.6.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.6.2. Argentina
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Competitive scenario
    • 8.6.2.3. Regulatory framework
    • 8.6.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
• 8.7. MEA
  • 8.7.1. South Africa
    • 8.7.1.1. Key country dynamics
    • 8.7.1.2. Competitive scenario
    • 8.7.1.3. Regulatory framework
    • 8.7.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.7.2. Saudi Arabia
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Competitive scenario
    • 8.7.2.3. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.7.3. UAE
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Competitive scenario
    • 8.7.3.3. Regulatory framework
    • 8.7.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.7.4. Kuwait
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Competitive scenario
    • 8.7.4.3. Regulatory framework
    • 8.7.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Company/Competition Categorization
• 9.2. Strategy Mapping
• 9.3. Company Market Position Analysis, 2024
• 9.4. Company Profiles/Listing
  • 9.4.1. Danaher Corporation
    • 9.4.1.1. Company overview
    • 9.4.1.2. Financial performance
    • 9.4.1.3. Product benchmarking
    • 9.4.1.4. Strategic initiatives
  • 9.4.2. Merck KGaA
    • 9.4.2.1. Company overview
    • 9.4.2.2. Financial performance
    • 9.4.2.3. Product benchmarking
    • 9.4.2.4. Strategic initiatives
  • 9.4.3. Revvity
    • 9.4.3.1. Company overview
    • 9.4.3.2. Financial performance
    • 9.4.3.3. Product benchmarking
    • 9.4.3.4. Strategic initiatives
  • 9.4.4. Maravai LifeSciences
    • 9.4.4.1. Company overview
    • 9.4.4.2. Financial performance
    • 9.4.4.3. Product benchmarking
    • 9.4.4.4. Strategic initiatives
  • 9.4.5. GenScript
    • 9.4.5.1. Company overview
    • 9.4.5.2. Financial performance
    • 9.4.5.3. Product benchmarking
    • 9.4.5.4. Strategic initiatives
  • 9.4.6. Beam Therapeutics
    • 9.4.6.1. Company overview
    • 9.4.6.2. Financial performance
    • 9.4.6.3. Product benchmarking
    • 9.4.6.4. Strategic initiatives
  • 9.4.7. Intellia Therapeutics, Inc.
    • 9.4.7.1. Company overview
    • 9.4.7.2. Financial performance
    • 9.4.7.3. Product benchmarking
    • 9.4.7.4. Strategic initiatives
  • 9.4.8. Cellectis
    • 9.4.8.1. Company overview
    • 9.4.8.2. Financial performance
    • 9.4.8.3. Product benchmarking
    • 9.4.8.4. Strategic initiatives
  • 9.4.9. ElevateBio
    • 9.4.9.1. Company overview
    • 9.4.9.2. Financial performance
    • 9.4.9.3. Product benchmarking
    • 9.4.9.4. Strategic initiatives
  • 9.4.10. Creative Biogene
    • 9.4.10.1. Company overview
    • 9.4.10.2. Financial performance
    • 9.4.10.3. Product benchmarking
    • 9.4.10.4. Strategic initiatives
  • 9.4.11. Bio Palette Co., Ltd
    • 9.4.11.1. Company overview
    • 9.4.11.2. Financial performance
    • 9.4.11.3. Product benchmarking
    • 9.4.11.4. Strategic initiatives